Free Articles, Free Web Content, Reprint Articles
Wednesday, January 20, 2021
 
Free Articles, Free Web Content, Reprint ArticlesRegisterAll CategoriesTop AuthorsSubmit Article (Article Submission)ContactSubscribe Free Articles, Free Web Content, Reprint Articles
 

Ketamine Infusion Therapy For Psychiatry Disorders and Chronic Pain Management

Over several decades, research has shown that ketamine has anti depressive properties. Ketamine is approved by the U.S FDA for the induction and management of anaesthesia , although it is being used for the management of psychiatry disorders and chronic pain management.

IV ketamine therapy is not a first line therapy for psychiatric disorders or chronic pain management and may be considered by the patient’s interdisciplinary team after failure of standard treatment.

The dose, frequency, and length of ketamine infusion treatment are individualized to each patient’s conditions, needs, and responsiveness to therapy with input from pain management team. Serial infusions appear to be more effective than a single infusion for psychiatry disorders and chronic pain conditions

USE FOR PSYCHIATRY DISORDERS:

Because major psychiatry disorders, such as MDD, are among the most disabling mental, neurological, and substance use-related illnesses and acute migraine, new therapeutic approaches are being considered to treat or delay the onset of these disorders.

IV low-dose Ketamine can induce rapid and robust, although temporary, ANTI-DEPRESSIVE effects, even in treatment resistant patients who do not respond to ECTs.

USE FOR CHRONIC PAIN TREATMENT:

Ketamine may be used for chronic pain management for a range of disorders, including CRPS (complex regional pain syndrome), ischemic limb pain, phantom limb pain, fibromyalgia and neuropathic pain, post herpetic neuralgia, trigeminal neuralgia, post nerve injury and chronic myofascial pain.

Ketamine may have a role as an opiate adjunct for CANCER PAIN, primary of neuropathic origin, and may be a treatment option for patients who cannot tolerate opioid responsiveness.

CONCLUSIONS:

The current literature suggests that ketamine in sub anaesthetic dose can provide short-term relief of refractory neuropathic pain and symptomatic relief in psychiatry disorders who are since long on oral antidepressants.

Ketamine should only be used after careful assessment of risk/ benefit for the individual patient and should be administered by pain clinic specialists, who are willing to follow patients closely.

Chronic pain and depression is something that millions of people deal with everydayBusiness Management Articles, and it can truly hinder their ability to live a normal and healthy life. Pain management clinics and psychiatry centres are places that specialize in helping people to ease the pain and stress that they feel every single day.

Shalby hospital’s Psychiatry Clinic and De Addiction Centre is committed to relieving your pain.

Article Tags: Chronic Pain Management, Ketamine Infusion, Psychiatry Disorders, Chronic Pain, Pain Management

Source: Free Articles from ArticlesFactory.com

ABOUT THE AUTHOR


About Author

Dr. Kalrav Mistry
Consultant - Psychiatry
Shalby Hospitals, Ahmedabad
For More Details +91 95120 49755



Health
Business
Finance
Travel
Technology
Home Repair
Computers
Marketing
Autos
Education
Entertainment
Family
Law
Communication
Other
ECommerce
Sports
Home Business
Internet
Self Help
Partners


Page loaded in 0.198 seconds